Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Authors :: Todd M. Bauer
Mark K. Bennett
Keith Orford
Sam H. Whiting
Yonchu Jenkins
Johanna C. Bendell
Ramaprasad Srinivasan
Bradley Carthon
Taofeek K. Owonikoko
Martin H. Voss
James J. Harding
Manish R. Patel
Naomi B. Haas
Angela DeMichele
Alice C. Fan
Melinda L. Telli
Richard J. Lee
Othon Iliopoulos
Nizar M. Tannir
Funda Meric-Bernstam
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Full Text Access

Tools